REFERENCES
- Jonsson P. Danneskiold-Samsoe B, Heggestad T, Iversen P. Leisti S. Management of early prostatic cancer in the Nordic countries: variations in clinical policies and physicians attitudes towards radical treat-ment options. Int J Tech Ass 1995; 11: 66–78.
- Iversen P. Prostate cancer. Editorial. Ugeskr Leger 1997; 159: 2519 (in Danish).
- Storm H, Manders T, Lecker S. Cancer incidence in Denmark 1991. Copenhagen: Danish Cancer Registry, 1994.
- Moller H, Mellemgaard A, Lindvig K, Olsen J. Obesity and cancer risk: a Danish record-linkage study. Eur J Cancer 1994; 30A: 344–50.
- The Danish National Board of Health. Evaluation of the Danish Hospital Discharge Registry, 2nd edd. Copenha-gen: The Danish National Board of Health, 1993.
- Brasso K, Friis S, Kjwr SK, Jorgensen T, Iversen P. Prostate cancer in Denmark: a 50-year population-based study. Urology 1998; 51: 590–4.
- Hakama M, Hakulinen T. Estimating the expectation of life in cancer survival studies with incomplete follow-up information. J Chron Dis 1997; 30: 585–97.
- Prener A, Kjwr S. Prostate cancer in Denmark. Ugeskr Leger 1987; 149: 1705–7 (in Danish).
- Harvei S, Tretli S, Langmark F. Cancer of the prostate in Norway 1957–1991. A descriptive study. Eur J Cancer 1996; 32A: 111–7.
- Whittemore A. Prostate cancer. Cancer Surveys 1994; 19/20: 309–22.
- Lu-Yao G, Greenberg E. Changes in prostate incidence and treatment in USA. Lancet 1994; 343: 1211–16.
- Potosky A, Miller B, Albertsen P, Kramer B. The role of increasing detection in the rising incidence of prostate cancer. JAMA 1995; 273: 548–52.
- Albertsen P. Fryback D, Storer B, Kolon T, Fine J. Long-term survival among men with conservatively treated localized prostate cancer. JAMA 1995; 274: 626–31.
- Chodak G, Thisted R, Gerber G, Johansson J, Adolfsson J, Jones G, et al. Results of conservative management of clinically localized prostate cancer. N Engl J Med 1994; 330: 242–8.
- Johansson J, Holmberg L, Johansson S, Bergstrom R, Adami H. Fifteen-year survival in prostate cancer. JAMA 1997; 277: 467–71.
- McLaren DB, McKenzie M, Duncan G, Pickles T. Watchful waiting or watchful progression? Prostate specific antigen doubling times and clinical behavior in patients with early untreated prostate carcinoma. Cancer 1998; 82: 342–8.
- Aus G, Hugosson J, Norlen L. Need for hospital care and palliative treatment for prostate cancer treated with noncurative intent. J Urol 1995; 154: 466–9.
- Bone M, Nerstrom B, Overgaard J. Prostate cancer-an expensive dilemma. Ugeskr Leger 1997; 159: 2534–7 (in Danish).
- Carlsson P. Hjertberg H, Jonsson B, Varenhorst E. The cost of prostatic cancer in a defined population. Scand J Urol Nephrol 1989; 23: 93–6.
- Handley R, Can W, Powell P, Hall R. Deferred treatment for prostate cancer. Br J Urol 1988; 62: 249–53.
- Otnes B, Harvei S, Fossa. S. The burden of prostate cancer from diagnosis to death. Br J Urol 1995; 76: 587–94.
- Cullen D, Apolone G, Greenfield S, Guadagnoli E, Cleary P. ASA physical status and age predict morbidity after three surgical procedures. Ann Surg 1994; 220: 3–9.
- Thorpe A, Cleary P, Coles J, Vernon S, Reynolds J, Neal D. Deaths and complications following prostatectomy in 1400 men in the Northern Region of England. Br J Urol 1994; 74: 559–65.
- Adami H-0, Norlen BJ, Malker B, Meirik O. Long-term survival in prostatic carcinoma, with special reference to age as prognostic factor. Scand J Urol Nephrol 1986; 20: 107–12.
- Bone M, Nerstrom B, Overgaard J. The natural history of prostate carcinoma based on a Danish cancer population treated with no intent to cure. Cancer 1997; 80: 917–28.
- Gronberg H, Damber J, Jonsson H, Lenner P. Patient age as a prognostic factor in prostate cancer. J Urol 1994; 152: 892–5.
- gronberg H, Bergh A, Damber J, Jonsson H, Lenner P. Angstrom T. Prostate cancer in Northern Sweden. Acta Oncologica 1994; 33: 359–63.
- Helgesen F, Holmberg L, Johansson J, Bergstrom R, Adami H. Trends in prostate cancer survival in Sweden 1960 through 1988: evidence of increasing detection of nonlethal tumors. J Natl Cancer Inst 1996; 88: 1216–21.
- Moller H, Friis S, Kjwr K. Survival of Danish cancer patients. Male genital organs. APMIS 1993; 101 Suppl 3: 122–36.
- Stattin P. Bergh A, Karlberg L, Tavelin B, Damber J. Long-term outcome of conservative therapy in men presenting with voiding symptoms and prostate cancer. Eur J Urol 1997; 32: 404–9.